15 March 2019
The following amendment has been made to the 'Total Voting Rights and Notice of Results' announcement released on 15 March 2019 at 08.10 a.m. under RNS No. 0010T.
The number of Ordinary Shares in issue was incorrectly stated. The correct number of Ordinary Shares in issue is 736,533,946.
All other details remain unchanged. The full amended text is shown below.
Total Voting Rights
Further to its announcement of 11 March 2019 ("Announcement") and following the admission to trading on AIM of the Initial Consideration Shares earlier today, DeepMatter, the AIM-listed company focusing on digitizing chemistry, is pleased to confirm that completion of the acquisition of InfoChem has occurred, with the Company successfully raising, in total, over £4.0 million via the Placing.
Therefore, the Company currently has 736,533,946 Ordinary Shares in issue, each with voting rights. This figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules. The Company does not hold any Ordinary Shares in Treasury.
Capitalised terms used in this announcement have the meaning (unless the context otherwise requires) as set out in the Announcement and the circular dated 22 February 2019, which is available on the Company's website www.deepmattergroup.com.
Notice of Results
The Company expects to release its audited final results for the year ended 31 December 2018 in mid-April 2019.
For further information:
|DeepMatter Group plc||T: 0141 548 8156|
|Mark Warne, Chief Executive Officer|
|Stockdale Securities Limited||T: 020 7601 6100|
|T: 020 3405 0209
DeepMatter's long term strategy is to integrate chemistry with technology, thereby enabling a greater use of artificial intelligence and reaching a point where chemicals can be autonomously synthesised through robotics. In the near term this involves the provision of an integrated software, hardware and artificial intelligence enabled platform, DigitalGlassware™, to scientists across research and process development sectors.
The DigitalGlassware™ platform allows chemistry experiments to be accurately and systematically recorded, coded and entered into a shared data cloud. The platform is designed to enable chemists to work together effectively; sharing the details of their experiments from anywhere and in real-time, so that work is not needlessly duplicated, time and money wasted, and ultimately so new discoveries may be made faster.
More information is available here: http://www.deepmattergroup.com